| Source: |
| Type: |
| NKX3.1 is a prostatic tumor suppressor gene located on chromosome 8p. Commonly down-regulated in human prostate cancer. NKX3.1 is a homeobox transcription factor that is normally highly expressed in prostate luminal epithelial cells. – During prostate tumorigenesis, NKX3.1 expression is frequently downregulated or lost, particularly in higher-grade lesions and advanced disease. Reduced or absent NKX3.1 expression is generally associated with poor prognosis. Loss of NKX3.1 leads to: -Increased oxidative DNA damage -Impaired DNA repair fidelity -Dedifferentiation of prostate epithelium -Increased susceptibility to oncogenic transformation (e.g., cooperation with PTEN loss) NKX3.1 loss does not drive proliferation directly—it removes safeguards that normally restrain malignant evolution. |
| 70- | QC, | Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | LAPC-4 |
| 75- | QC, | Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells |
| - | in-vitro, | Pca, | HEK293 | - | in-vitro, | NA, | 22Rv1 | - | in-vitro, | NA, | C4-2B |
| 82- | QC, | AG, | Arctigenin in combination with quercetin synergistically enhances the anti-proliferative effect in prostate cancer cells |
| - | in-vitro, | Pca, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:387 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid